Image of DXNA logo
  • Contact Us
  • |
  • Careers
    • About DxNA
      • History
    • Executive Team
    • Board of Scientific Advisors
    • Partnering Opportunities
      • Distribution
      • OEM Licensing
      • 3rd Party Integration
    • Careers
    • News & Events
      • DxNA In the News
      • Press Releases
      • Industry Headlines
        • H5N1 - Avian Influenza
        • Malaria
        • Exotic Newcastle DIsease
        • PRRS - Porcine Reproductive and Respiratory Syndrome
        • African Swine Fever
    • Why DxNA
    • Genetic Molecular Analyses
    • Situation Analysis
    • Vital Role of Genetic Testing
    • Overview
    • Biodefense
    • Human Medicine
    • Veterinary Medicine
    • Agriculture
    • Food & Beverage Safety
    • Overview
    • What We Test For
    • Tests & Reagents
    • Request a Test
    • FAQ
    • White Paper
  • Search:
About DxNA
Executive Team
Board of Scientific Advisors
Partnering Opportunities
Careers
News & Events
DxNA In the News
Press Releases
Industry Headlines
H5N1 - Avian Influenza
Malaria
Exotic Newcastle DIsease
PRRS - Porcine Reproductive and Respiratory Syndrome
African Swine Fever

In the News 
 

DxNA Exhibits GeneSTAT's Groundbreaking
Technology inAvian Influenza Diagnostics and
Global Pandemic Prevention




At the DxNA booth at the 7th International Bird Flu Summit, Chief Operations Officer Ernest Sumsion performs a GeneSTAT demonstration for a conference attendee.

DxNA Chief Executive Officer, Phillip Grimm, addresses the 7th International Bird Flu Summit in November 2008.


 

DxNA Chief Operations Officer, Ernest Sumsion and the Minister of Health of Indonesia, Dr. Siti Fadilah Supari, discuss DxNA's technology. 




DxNA Chief Business Development Officer, Craig Mosman, speaks at the 7th International Bird Flu Summit in November 2008.


DxNA Chief Science Officer, Dr. Mark Rosenfeld, discusses the capability of DxNA's technology to diagnose H5N1.

  • site map
  • |
  • privacy
  • |
  • Copyright © 2012 DxNA LLC